300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Kuwait
China
Armenia
Costa Rica
Czech Republic
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Emertec, VC Fund

Emertec

VC Fund

Grenoble, France

Emertec is a VC fund in Grenoble focused on Energy and Electronics. EMERTEC’s experienced investment team has developed proven track record and has been able to develop close ties with major industrial players, many of them also being investors in their funds.These close ties are extremely valuable as to understand medium and long-term requirements of major order placers and high-level commercial opportunities. This brings visibility and confidence for entrepreneurs as well as for its investors. Their objective is to create value by turning ground-breaking technological innovations into commercial and financial successful companies.

Total investments:
30
Last investment:
Lead investor:
7%
Fund size:
$78M
Last fund:

Last updated:

Industries Emertec invests in

EnergyElectronicsBiotechnologyHardwareSoftware

Stages Emertec invests in

Series AVenture - Series UnknownSeedSeries BSeries C

Countries Emertec invests in

FranceCanadaSwitzerlandUnited States

Round sizes

Seed $1.5M–$3.3MSeries A $1.4M–$6.8MVenture - Series Unknown $566k–$6M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$1.5M–$3.3M
Series A
$1.4M–$6.8M
Venture - Series Unknown
$566k–$6M

Investment Focus

Industry

  • Energy 6 (20%)
  • Electronics 6 (20%)
  • Biotechnology 5 (17%)
  • Hardware 4 (13%)
  • Software 4 (13%)
See all 46 industries →

Stage

  • Series A 9 (30%)
  • Venture - Series Unknown 8 (27%)
  • Seed 4 (13%)
  • Series B 4 (13%)
  • Series C 1 (3%)
See all 7 stages →

Country

  • France 22 (73%)
  • Canada 1 (3%)
  • Switzerland 1 (3%)
  • United States 1 (3%)

Team

NameTitleInvestmentsLinksEmail
Jean-Philippe Gendre
Jean-Philippe Gendre Member, Board of Directors
Member, Board of Directors Total investments: 1 Find email

Investments

CompanyDescriptionRoundLinks
MESA Imaging is focusing on the development and production of 3D time-of-flight cameras. $4.3M / Series A / Jan 01, 2019
Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France. $1.2M / Venture - Series Unknown / Oct 17, 2017
Sencrop is an ag-tech startup that offers an in-field data-based platform to empower farmers to make better decisions in their daily agricultural activities. Sencrop designs and sells connected weather forecast solutions for farmers to measure rain, hygrometry, and wind speed. The sensors are cheap, robust, movable, and easy to use, making moreefficient and sustainable farming possible $1.5M / Seed / Jan 12, 2017
Ynsect provides products and services that operate in the agro-food and environmental biotech industries. It uses the potential of insect nutrients and behaviors to develop novel products and services in collaboration with their clients. Since 2011, Ÿnsect has been transforming farmed insects into premium animal nutrition. They are developinginnovations to farm insects at large scale and automating processes to turn insects into the highest quality raw materials for animal feed. Its unique know-how makes Ÿnsect a preferred partner among agri-food professionals, laboratories, investors, public institutions, and insect industry farmers. $15.2M / Series B / Dec 14, 2016
Nexdot develops the synthesis, the production, and the applications of a new generation of semiconductor nanocrystals with controlled size and shape: Quantum Dots (QDs). We are the world leader for the development of nanoplatelets – 2D nanosheet Quantum Dots with upgraded properties.They are a spin-off company from a world-class academic lab atESPCI (Paris, France) in nanomaterial research and we benefit from more than ten years of experience in fundamental and applied research on nanomaterials and their technological applications. After four years of intense internal R&D efforts, we have developed unique know-how for the production of colloidal Quantum Dots and Nanoplatelets, Our proprietary materials with controlled shape and composition are unique and bring new expectations for use in displays, lighting, energy storage, detectors, and bio-imaging. Nexdot gathers young, enthusiastic, top level scientists and a board of senior executives with very strong track records on company management and innovation leadership. $3.7M / Venture - Series Unknown / Dec 14, 2016
eLichens' mission is to provide relevant and comprehensive information about the air they breathe. The company relies on a portfolio of patents, know-how and skills that enable a complete air quality solution (sensors and services) and address both consumer electronics and industrial markets. eLichens has its offices in Grenoble, France andin the Silicon Valley California, USA. $3.4M / Venture - Series Unknown / Jul 29, 2016
Deepki is the most trusted sustainability solution for real estate. The complete SaaS platform helps asset owners and investors manage risk, enhance financial performance, and meet rising expectations from regulators and stakeholders with data-driven insights. They support clients in creating clear, actionable plans for both climate transition andadaptation—delivering quantifiable environmental and financial outcomes.With 600+ customers and 70,000 users, Deepki monitors €4T in assets across 90+ countries and 60+ asset types, serving clients such as Generali Real Estate, PGIM, Swiss Life, and the French government. Deepki holds both ISAE 3000 Type II and SOC 2 Type II reports, meeting the highest standards for data security, credibility and auditability.With 500+ customers and 50,000 users, Deepki monitors €4T in assets across 80+ countries and 60+ asset types, serving clients such as Generali Real Estate, PGIM, Swiss Life, and the French government. Their platform is also ISAE 3000 Type 2 certified, which meets the highest standards for data credibility and auditability. $2.3M / Series A / Jun 23, 2016
Naio Technologies develops and markets machines for agriculture and viticulture. It features electric tools for weeding, hoeing, and harvesting that help farmers collect and harvest their products. The company specializes in agriculture, AI, robotics, and Agtech. Naio Technologies was founded in 2011 and headquartered in Midi-Pyrenees, France. $3.3M / Seed / Dec 22, 2015
Defymed is a worldwide leader in the development of innovative implantable medical devices that change the paradigm of therapeutics' administration. Defymed's innovations were developed to limit adverse events related to current standard of care based on site specific delivery of therapeutics. Our solutions aim for a preciseadministration of drugs, in a physiologic site, in order to improve disease's management and patients' quality of life. Up to date, two first in class technologies were developed by Defymed: MailPan®, a physiologic cell encapsulation device, and ExOlin®, a targeted drug delivery device (in clinics). Defymed owns an exclusive technology and know-how which positions its medical devices as a platform to meet several therapeutic applications, among which type 1 diabetes, hemophilia and cancer management. Defymed is certified ISO13485:2016. Defymed relies also on a strong and unique worldwide network gathering experts from the cell therapy and drug delivery fields. Defymed has been rewarded several times in Europe and in the USA, for its unique approaches to reinvent patients' journey. $2.8M / Seed / Oct 27, 2015
Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France. $565.6K / Venture - Series Unknown / Sep 14, 2015
See all 30 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Kuwait
China
Armenia
Costa Rica
Czech Republic
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Emertec invest in?

Emertec invests primarily in Energy, Electronics and Biotechnology startups, most often at Series A and Venture - Series Unknown stage. Most of the 30 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Emertec invest in?

Emertec typically joins rounds of $1.5M–$3.3M at Seed, $1.4M–$6.8M at Series A and $566k–$6M at Venture - Series Unknown. These are whole funding-round sizes, not Emertec's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Emertec took part in.

How do I contact Emertec?

Public channels for Emertec include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Emertec?

The team at Emertec includes Jean-Philippe Gendre (Member, Board of Directors). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Emertec Emertec Find emails